New drug duo aims to shrink head and neck tumors before surgery
NCT ID NCT07586124
First seen May 20, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tests whether adding two drugs (pucotenlimab and becotatug vedotin) to standard surgery can improve outcomes for people with advanced head and neck cancer that can be removed. About 80 participants will receive the drug combination or a placebo before and after surgery. The main goal is to see how many tumors shrink significantly or disappear completely after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, 515041, China
Contact
-
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, 530021, China
Contact
-
Hubei Cancer Hospital
Wuhan, Hubei, 430079, China
Contact
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
Contact
-
Liaoning Cancer Hospital & institute
Shenyang, Liaoning, 110042, China
Contact
-
Ningbo Medical Center Lihuili Hospital
Ningbo, Zhejiang, 315040, China
Contact
-
Peking University Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Contact
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200120, China
Contact
-
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200011, China
Contact
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510120, China
Contact
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Contact
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, 350005, China
Contact
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050011, China
Contact
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Contact
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
Contact
Conditions
Explore the condition pages connected to this study.